Delivery Order SPE2DB22D1017-SPE2DB25FG7FM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,028.16 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $10,409.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order was performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.14 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60 count) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger federal pharmaceutical supply agreements. The work will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $25,905.55 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item fulfilling pharmaceutical supply...
- The Defense Logistics Agency awarded a $12,241.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract was competitively awarded and performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $10,886.77 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on June 4, 2025, with an ultimate completion date of June 5, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency awarded a $4,865.97 delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 4, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $14,041.46 to AmerisourceBergen Drug Corp for IBSRELA 50 MG tablets (60-count packages) on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,477.01 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,086.77 to AmerisourceBergen Drug Corp for the supply of Ibsrela 50 mg tablets (60-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7FMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,980.60 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's role as a global pharmaceutical prime vendor demonstrates its capability to fulfill diverse medical commodity requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 7/14/25 |